tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Belluscura Achieves Record Sales and Initiates Strategic Review

Story Highlights
Belluscura Achieves Record Sales and Initiates Strategic Review

TipRanks Cyber Monday Sale

The latest announcement is out from Belluscura PLC ( (GB:BELL) ).

Belluscura PLC announced a record sales month for its X-PLOR portable oxygen device, despite earlier supply challenges, and is on track for the commercial launch of its DISCOV-R product. The company has initiated a strategic review to explore options for strengthening its capital position to support growth and profitability, including potential investments and partnerships.

More about Belluscura PLC

Belluscura PLC is a UK-based medical device company specializing in oxygen enrichment technology. The company focuses on developing products for various industries and therapies, particularly portable oxygen solutions.

Average Trading Volume: 2,364,964

Technical Sentiment Signal: Sell

Current Market Cap: £2.71M

See more insights into BELL stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1